A decade of increases in Medicare Part B pharmaceutical spending: what are the drivers?

BACKGROUND: Medicare Part B pharmaceutical spending has increased rapidly, more than doubling in 2006-2017. Yet, it is unclear whether this increase was driven by increased utilization or increased cost per claim. OBJECTIVE: To evaluate the relative impact of changes in drug utilization and cost per...

Descripción completa

Detalles Bibliográficos
Autores principales: San-Juan-Rodriguez, Alvaro, Gellad, Walid F, Shrank, William H, Good, Chester B, Hernandez, Inmaculada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906185/
https://www.ncbi.nlm.nih.gov/pubmed/33908276
http://dx.doi.org/10.18553/jmcp.2021.27.5.565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906185/
https://www.ncbi.nlm.nih.gov/pubmed/33908276
http://dx.doi.org/10.18553/jmcp.2021.27.5.565

Ejemplares similares